Puma Biotechnology reported $44.6M in Gross Profit on Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
TG Therapeutics TGTX:US 571K 1.21M
Agios Pharmaceuticals AGIO:US $ 5.15M 4.65M
Alnylam Pharmaceuticals ALNY:US $ 184.01M 6.38M
Amgen AMGN:US $ 5084M 407M
Biogen BIIB:US $ 2105.1M 327.2M
Biomarin Pharmaceutical BMRN:US $ 410.67M 8.28M
Bluebird Bio BLUE:US $ -226000 6.14M
Clovis Oncology CLVS:US $ 22.93M 1.91M
Daiichi Sankyo 4568:JP Y 205519M 60424M
Esperion Therapeutics ESPR:US $ 9.66M 2.05M
Exelixis EXEL:US $ 405.95M 63.17M
Gilead Sciences GILD:US $ 4818M 348M
Glaxosmithkline GSK:US $ 4793M 1342M
Intercept Pharmaceuticals ICPT:US $ 71.45M 16.38M
MacroGenics MGNX:US 23.6M 12.55M
Moderna Inc MRNA:US 3.37B 1.68B
Novartis NOVN:VX 9.34B 277M
Pfizer PFE:US $ 19071M 3420M
Ptc Therapeutics PTCT:US $ 155.89M 17.29M
Puma Biotechnology PBYI:US $ 44.6M 9.71M
Regeneron Pharmaceuticals REGN:US $ 2560.1M 0.1M
Sarepta Therapeutics SRPT:US $ 195.69M 16.3M
Seattle Genetics SGEN:US $ 391.4M 52.57M
Takeda 4502:JP Y 679583M 114674M
Ultragenyx Pharmaceutical RARE:US $ 81.07M 7.24M
Vertex Pharmaceuticals VRTX:US $ 1934.4M 82.7M
YTE INCY:US $ 866.16M 170.14M